Khartis Therapeutics
Develops oral small molecule therapies for immunological and chronic diseases
$50MSeries B
Role not disclosedLF
Longwood Fund
Activity from announced rounds
Activity in this selectionHealthtech
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $126M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionMediar Therapeutics
Develops therapies to halt fibrosis in multiple organ systems
$76MSeries B
Role not disclosed